ClearPoint Neuro, Inc.
$11.16
▲
2.52%
2026-04-21 06:05:00
www.clearpointneuro.com
NCM: CLPT
Explore ClearPoint Neuro, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$349.74 M
Current Price
$11.16
52W High / Low
$30.1 / $8.27
Stock P/E
—
Book Value
$0.95
Dividend Yield
—
ROCE
-27.78%
ROE
-95.64%
Face Value
—
EPS
$-0.9
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
172
Beta
1.18
Debt / Equity
207.82
Current Ratio
5.91
Quick Ratio
5.13
Forward P/E
-10.65
Price / Sales
6.98
Enterprise Value
$269.79 M
EV / EBITDA
-12.56
EV / Revenue
7.3
Rating
None
Target Price
$25
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Butterfly Network, Inc. | $5.49 | — | $1.39 B | — | -37.34% | -42.25% | $5.62 / $1.32 | $0.77 |
| 2. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
| 3. | Envoy Medical, Inc. | $0.7 | — | $54.48 M | 3.34% | 741.34% | 155.22% | $1.91 / $0.36 | $-0.41 |
| 4. | SANUWAVE Health, Inc. | $19.94 | 14.99 | $177.13 M | — | 25.36% | -166.66% | $46.59 / $16.27 | $0.19 |
| 5. | OrthoPediatrics Corp. | $16.65 | — | $420.89 M | — | -6.27% | -11.31% | $23.7 / $14.91 | $13.81 |
| 6. | Bio-Rad Laboratories, Inc. | NOT FOUND | — | — | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 7. | NeuroOne Medical Technologies Corporation | $4.98 | — | $40.89 M | — | -49.83% | -1.46% | $6.96 / $3 | $0.13 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 10.41 M | 8.86 M | 9.21 M | 8.48 M | 7.77 M | — |
| Operating Profit | -7.04 M | -5.28 M | -5.68 M | -6.16 M | -5.6 M | — |
| Net Profit | -7.79 M | -5.89 M | -5.84 M | -6.03 M | -5.39 M | — |
| EPS in Rs | -0.26 | -0.2 | -0.2 | -0.2 | -0.18 | -0.18 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 36.97 M | 31.39 M | 23.95 M | 20.55 M |
| Operating Profit | -24.16 M | -19.73 M | -22.45 M | -16.33 M |
| Net Profit | -25.54 M | -18.91 M | -22.09 M | -16.43 M |
| EPS in Rs | -0.86 | -0.64 | -0.74 | -0.55 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 97.75 M | 39.19 M | 42.66 M | 55.49 M |
| Total Liabilities | 69.73 M | 13.8 M | 21.49 M | 18.6 M |
| Equity | 28.02 M | 25.39 M | 21.17 M | 36.89 M |
| Current Assets | 63.6 M | 33.36 M | 36.17 M | 51.18 M |
| Current Liabilities | 10.77 M | 10.35 M | 7.43 M | 6.79 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -23.93 M | -8.95 M | -13.72 M | -16.17 M |
| Investing CF | 0.61 M | -0.28 M | 8.95 M | -10.74 M |
| Financing CF | 50.18 M | 6.19 M | 0.3 M | 0.41 M |
| Free CF | -24.45 M | -9.22 M | -14.77 M | -17.31 M |
| Capex | -0.52 M | -0.28 M | -1.05 M | -1.15 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 31.04% | 16.56% | — | — |
| Earnings Growth % | 14.37% | -34.4% | — | — |
| Profit Margin % | -60.25% | -92.21% | -79.97% | — |
| Operating Margin % | -62.87% | -93.7% | -79.47% | — |
| Gross Margin % | 60.92% | 56.83% | 65.84% | — |
| EBITDA Margin % | -52.5% | -87.62% | -75.8% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.